Navigation Links
Medtronic Device Proves Effective in Parkinson’s Diseas

A recent study has shown that Medtronic Inc.'s (MDT) Activa brain stimulation device, in combination with medication is shown to improve motor functions// as well as quality of life in patients with advanced Parkinson's disease more than in patients receiving only medication.

The study was published in Thursday's issue of the New England Journal of Medicine.

In 2002 the Food and Drug Administration had approved the Activa deep brain stimulation therapy to treat Parkinson's. While earlier studies mainly looked at brain stimulation in treating motor functions, this study looked at quality of life as a main endpoint, in addition to motor functions.

Dr. Richard Kuntz, president of the neurological division of the Minneapolis medical-device company told that the results validate Activa's value by providing additional clinical evidence from this study that was more rigorous than past studies.

This six-month study was conducted on 156 patients below 75 years of age who have had Parkinson's for at least five years and suffer from impaired mobility despite medication. During the study all the patients received medication, and half received neurostimulation treatment with the Activa device.

Patients receiving neurostimulation saw a 25% improvement in quality of life and a 41% improvement in motor functions, compared with virtually no change in patients receiving only medication.

The study reports, "In carefully selected patients, neurostimulation of the subthalamic nucleus is a powerful treatment that alleviates the burden of advanced Parkinson's disease."

The Activa device includes electrodes surgically implanted in the brain and connected by an extension under the skin to a neurostimulator implanted near the collarbone. The electrical stimulation can be noninvasively adjusted.

The study was conducted by German and Austrian researchers. Medtronic has awarded some of the researche
'"/>




Page: 1 2

Related medicine news :

1. Medtronic’s Insulin Pump Receives Regulatory Approva
2. Injection supports Heart Devices
3. New Heart-Screening Device ,An Accurate Predictor Of Heart Disease
4. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
5. Withdrawal Notice Issued For Older Pacemakers Due To Malfunctioning of the Device
6. New Implantable Device That Can Keep The Heart Ticking
7. Making MRIs Safe for Patients With Implantable Heart Devices
8. Researchers Develop Device For Detecting Atherosclerotic Plaques
9. A Cheap Device to Stop Snoring from New Zealand
10. Scientists Concerned Over Increasing Malfunction Of Heart Devices
11. Device For Improving Bone Mass In Osteoporosis
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...scientists working at the epicenter of the AIDS ep...an immunodeficiency virus// (HIV) “exhausts” kille...he researchers found that HIV can simply “turn off...r switch on the cells. In test tube studies, howev...
...problems in cataract surgery is higher in patients... treat an enlarged prostate.// According to the 3...thalmology, the American Society of Cataract and R...ogical Association, mentioning the use of drugs li...
...d have been the cause of the recent U.S. outbreak ...solution according to researchers on Tuesday.// W... received multiple reports of the corneal infectio... solution Renu with MoistureLoc was recalled from ...
...ho are anxious before surgery have a more complica...was conducted by the Yale School of Medicine// stu...diatrics, Children who are anxious before surgery ...omplicated postoperative recovery. Zeev Kain, M.D...
Other Medicine News:Health News:How HIV "Exhausts" Killer T Cells 2Health News:How HIV "Exhausts" Killer T Cells 3Health News:How HIV "Exhausts" Killer T Cells 4Health News:Alpha-blockers call for modification in cataract surgery 2Health News:Alpha-blockers call for modification in cataract surgery 3Health News:Corneal infections Linked to External Contamination 2Health News:Anxiety In Children Prior To Surgery Might Complicate Recovery 2
(Date:10/9/2008)...Newswire-FirstCall/ -- Diamyd Medical reports,that... New England Journal,of Medicine, has published an...the Diamyd(R) diabetes vaccine for type 1 diabetes...080314/297194 ), The article is now available on...d will be in print on October 30. It presents the,...
(Date:10/8/2008)...Pioneers Research That May Offer New Hope to,Heart...- Nationally, over 3,000 people are,waiting for a ... only half,of those will receive a transplant. Now...AHI) is paving the way for how to treat congestive...media News Release, go to:, http://www.prnewswire....
(Date:10/8/2008)...otency of Poly-ICR as Vaccine Adjuvant, SAN DIEGO...aceuticals,Corporation (TSX: NVN) today presented ...roprietary Toll-like Receptor 3 agonist, Poly IC-P...ress 2008 in Lyon, France.,Study results demonstra...ting the Toll-like Receptor 3 (TLR3) pathway. Data...
(Date:10/7/2008)...Newswire/ -- McLaren Health Care and its Great,Lak...d,s leading medical,minds to share the latest work...estinal cancer treatments. The October 11th sympos...McLaren,s Sukamal Saha, M.D., an,award-winning sur...ng for,colorectal cancer has gained worldwide reco...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2Drop of Flu Vaccine Under Tongue Bars Infection 10284 1Drop of Flu Vaccine Under Tongue Bars Infection 10284 2Lessons from evolution applied to national security and other threats 2033 1Lessons from evolution applied to national security and other threats 2033 2Lessons from evolution applied to national security and other threats 2033 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 1Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 2Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 3Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 4Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 5Nycomeds Ciclesonide to be Commercialised in the United States by Sepracor 2783 6JDRF to establish an autoimmunity center at University of Colorado Denver 10275 1JDRF to establish an autoimmunity center at University of Colorado Denver 10275 2
... Calif., May 17, 2007 /PRNewswire-FirstCall/ -- DU...maceutical has,provided its shareholders with an u...Memryte, an investigational drug for the,treatment...shareholders that they have observed positive outc...ng men. DURECT has not,independently verified the ...
... Md., May 18, 2007 /PRNewswire-FirstCall/ -- Vanda... present four,posters on iloperidone at the 160th ...ing which will be held at the San,Diego Convention...24, 2007. , The following posters will be presente...San Diego Convention Center (Sails,Pavilion, Upper...
Other Medicine Technology:DURECT Provides an Update to the Memryte Program Under Development,by Voyager Pharmaceutical Corp 2Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007,American Psychiatric Association Annual Meeting 2
Phaco chopper 1 mm fully cutting edge.
Round handle dull finish. For right handed surgeon.
Specially designed wider jaws to help split soft nucleus, cross action, round handle, maximum opening 2.8 mm.
Irrigating nucleus chopper, tip angled 30 to side wedge shaped inferior edge with blunt tip and front notch for engaging iris end opening, 19 gauge. For use in the right hand.
Medicine Products: